Name: Novokinin
Rating: 5 (10 reviews)

有库存

sdf 文件

结构编辑

类似物检索

HIT ID:HIT212674720
Cas No:358738-77-9
常用名:Novokinin
IUPAC:(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-[(diaminomethylidene)amino]pentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid
IUPAC:(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-[(diaminomethylidene)amino]pentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid
InChI key:WCJSVACAALWGRF-LQPYQXOBSA-N

分子式:C39H61N11O7
分子量:795.987
氢键供体数 (HBD):9
氢键受体数 (HBA):12
LogP:-2.7142606
SMILES:CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O |wU:4.4,8.7,wD:27.27,15.16,39.41,43.44,(23.3,-8.38,;22.53,-7.04,;20.99,-7.04,;23.3,-5.71,;22.53,-4.38,;23.3,-3.04,;24.84,-3.04,;25.61,-4.38,;25.61,-1.71,;27.14,-1.55,;27.46,-.04,;26.12,.73,;24.98,-.3,;23.47,.02,;22.44,-1.13,;23,1.48,;24.03,2.63,;21.49,1.8,;21.01,3.27,;19.51,3.59,;19.03,5.05,;20.06,6.2,;19.59,7.66,;21.57,5.88,;20.99,-4.38,;20.22,-3.04,;20.22,-5.71,;18.68,-5.71,;17.91,-4.38,;16.37,-4.38,;15.6,-3.04,;14.06,-3.04,;13.29,-4.38,;17.91,-7.04,;18.68,-8.38,;16.37,-7.04,;15.46,-5.8,;14,-6.27,;14,-7.81,;15.46,-8.29,;15.94,-9.75,;17.44,-10.07,;14.91,-10.9,;15.38,-12.36,;14.35,-13.51,;14.83,-14.97,;16.29,-15.45,;16.29,-16.99,;14.83,-17.46,;14.2,-18.87,;12.67,-19.03,;11.76,-17.79,;12.39,-16.38,;13.92,-16.22,;16.89,-12.68,;17.36,-14.15,;17.92,-11.54,)|
SMILES:CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O |wU:4.4,8.7,wD:27.27,15.16,39.41,43.44,(23.3,-8.38,;22.53,-7.04,;20.99,-7.04,;23.3,-5.71,;22.53,-4.38,;23.3,-3.04,;24.84,-3.04,;25.61,-4.38,;25.61,-1.71,;27.14,-1.55,;27.46,-.04,;26.12,.73,;24.98,-.3,;23.47,.02,;22.44,-1.13,;23,1.48,;24.03,2.63,;21.49,1.8,;21.01,3.27,;19.51,3.59,;19.03,5.05,;20.06,6.2,;19.59,7.66,;21.57,5.88,;20.99,-4.38,;20.22,-3.04,;20.22,-5.71,;18.68,-5.71,;17.91,-4.38,;16.37,-4.38,;15.6,-3.04,;14.06,-3.04,;13.29,-4.38,;17.91,-7.04,;18.68,-8.38,;16.37,-7.04,;15.46,-5.8,;14,-6.27,;14,-7.81,;15.46,-8.29,;15.94,-9.75,;17.44,-10.07,;14.91,-10.9,;15.38,-12.36,;14.35,-13.51,;14.83,-14.97,;16.29,-15.45,;16.29,-16.99,;14.83,-17.46,;14.2,-18.87,;12.67,-19.03,;11.76,-17.79,;12.39,-16.38,;13.92,-16.22,;16.89,-12.68,;17.36,-14.15,;17.92,-11.54,)|

Angiotensin AT2 receptor agonist

市场产品/服务共显示1个结果

供应商
TargetMolSC
规格
货期
3-6月
纯度
-
待询
1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目？或者您需要定制解决方案？Anymole随时为您提供帮助。

电话：400820-0310

合作：info@screeningcompound.com

技术支持：tech@screeningcompound.com

客服：service@screeningcompound.com

正在加载 ~